LISA SATTER to Janus Kinase Inhibitors
This is a "connection" page, showing publications LISA SATTER has written about Janus Kinase Inhibitors.
Connection Strength
1.244
-
Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors. Am J Respir Crit Care Med. 2020 09 15; 202(6):893-897.
Score: 0.684
-
STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition. N Engl J Med. 2020 10 08; 383(15):1494-1496.
Score: 0.344
-
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev. 2024 03; 322(1):311-328.
Score: 0.216